Sunil Healthcare Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 251.84 million compared to INR 314.75 million a year ago. Revenue was INR 260.34 million compared to INR 316.29 million a year ago. Net loss was INR 0.794 million compared to net income of INR 21.62 million a year ago. Basic loss per share from continuing operations was INR 0.08 compared to basic earnings per share from continuing operations of INR 2.11 a year ago. Diluted loss per share from continuing operations was INR 0.08 compared to diluted earnings per share from continuing operations of INR 2.11 a year ago.
For the nine months, sales was INR 892.31 million compared to INR 871.69 million a year ago. Revenue was INR 927.7 million compared to INR 879.94 million a year ago. Net income was INR 62.32 million compared to INR 24.1 million a year ago. Basic earnings per share from continuing operations was INR 6.08 compared to INR 2.35 a year ago. Diluted earnings per share from continuing operations was INR 6.08 compared to INR 2.35 a year ago.